LoginRegister
    Owlstone Medical collaborates with Thermo Fisher Scientific to advance use of breath samples to detect diseaseOwlstone Medical collaborates with Thermo Fisher Scientific to advance use of breath samples to...
    Changsheng Life Sciences declared bankrupt in vaccine scandalChangsheng Life Sciences declared bankrupt in vaccine scandal
    Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 croreLupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore
    Health Ministry proposes to allow Nurses, Community health workers to store, dispense medicines; Pharmacists see RedHealth Ministry proposes to allow Nurses, Community health workers to store, dispense medicines;...
    Glenmark gets USFDA nod for generic version of Epiduo gel to treat acute acneGlenmark gets USFDA nod for generic version of Epiduo gel to treat acute acne
    Mega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 croreMega Deal: Novartis buys Aspen Pharma Japanese generic unit for over Rs 3154 crore
    Government approves 4 medical device parks to cut import bill, production costGovernment approves 4 medical device parks to cut import bill, production cost
    Lipocine testosterone drug Tlando fails for the thrid time to get USFDA approvalLipocine testosterone drug Tlando fails for the thrid time to get USFDA approval
    Merck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating AvelumabMerck, Pfizer announce topline results of Phase III JAVELIN Gastric 100 trial evaluating Avelumab
    USFDA nod to Reblozyl, Celgenes rare blood disorder drugUSFDA nod to Reblozyl, Celgene's rare blood disorder drug
    Wockhardt Q2 net loss widens to Rs 94 crWockhardt Q2 net loss widens to Rs 94 cr
    Glenmark recalls over 2 lakh cartons of product in USGlenmark recalls over 2 lakh cartons of product in US
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X